Hospital Design and Risk of Nosocomial Infections: A Prospective Controlled Trial

NCT00563186 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

1514

Enrollment

OTHER

Sponsor class

Conditions

Vancomycin Resistant Enterococci Infection
Clostridium Difficile Infection
Nosocomial Infection
Methicillin Resistant Staphylococcus Aureus Infection (MRSA)

Interventions

OTHER: Admission to a novel hospital ward

Sponsor

University of Calgary

Collaborators

[object Object]
[object Object]
[object Object]